4SCAR‐GD2‐modified T‐cell therapy in neuroblastoma with MYCN amplification: A case report with over 4‐year follow‐up data

INTRODUCTION: Neuroblastoma (NB) is the most common extracranial solid tumor among children. The 5‐year event‐free survival rate for high‐risk (HR) NB is still poor, especially for patients with advanced NB with MYCN gene amplification. Chimeric antigen receptor T (CAR‐T) cell therapy is a new treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiao, Zhao, Wen, Yue, Zhixia, Qin, Maoquan, Jin, Mei, Chang, Lung‐Ji, Ma, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331334/
https://www.ncbi.nlm.nih.gov/pubmed/32851343
http://dx.doi.org/10.1002/ped4.12181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331334/
https://www.ncbi.nlm.nih.gov/pubmed/32851343
http://dx.doi.org/10.1002/ped4.12181

Ejemplares similares